ASTECAstec LifeSciences Limited
Metals · Agricultural Inputs · NSE · as of 2026-09-11 (delayed ~30 min in market hours)
Astec LifeSciences Limited, together with its subsidiaries, manufactures and sells agrochemical active ingredients and pharmaceutical intermediates in India. The company provides triazole fungicides for use in field crops; foliar treatment for the control of scab, powdery mildew, shot-hole, blossom blight, and rust; seed treatment for the control of seed and soil-borne diseases in cotton and maize, as well as grains, such as barley, rice, and wheat; post-harvest drench; and food additive and wood preservatives. It also provides herbicides, insecticides, and specialty chemical products. The company also exports its products. The company was incorporated in 1994 and is based in Mumbai, India. Astec LifeSciences Limited operates as a subsidiary of Godrej Agrovet Limited.
Price & Volume
Loading chart…
Key Ratios
“—” means the figure isn't meaningful or isn't published for this company: ROE and Debt/Equity are undefined when shareholder equity is negative (check P/B — negative means negative equity), and DII/MF holding splits aren't provided by our current data source.
Active Pattern Signals
The picture
- • Profit growth: 39.9% YoY
- • Promoter holding: 73.1%
- • RSI: 63
- • MACD: fresh bullish crossover
- • Price vs EMA21: above
- • 1-month return: +16.2%
- • EMA Crossover signal (setup quality 81%)
Bull case
- • Profit growth: 39.9% YoY
- • Promoter holding: 73.1%
- • RSI: 63
- • MACD: fresh bullish crossover
Bear case
- • Revenue growth: -8.3% YoY
- • ROE: -20.7%
- • Golden cross setup: SMA50 below SMA200
- • Volume: 0.2x 20-day average
Key risks
- • Elevated volatility / drawdown profile — size positions accordingly
- • Weak fundamentals — technical strength may not sustain
- • Revenue growth: -8.3% YoY
- • ROE: -20.7%
Algorithmic analysis for research only — not SEBI-registered investment advice.
Trade Plan
Stop = 20-day support with a 2.5×ATR risk cap (ATR ₹38.12). Levels recompute on every data refresh. Position sizing and execution are yours — this is analysis, not advice.